In June 2016, the chief executive officer of a large pharmaceutical company stated, “Giving out free cancer drugs would not help the poorest parts of Africa.”1 He added that training doctors, not the cost of drugs, was the biggest issue in the world's poorest countries. While his position in part reflects real challenges that exist in resource-constrained settings, it overlooks what is possible and what has been done. Above all it perpetuates the fallacy that it is impossible to treat cancer in Africa. We believe that the counterfactual choice—what would happen if we give free cancer drugs to some parts of Africa where safe and effective cancer treatment centers exist?—should be emphasized.
Martei YM, Binagwaho A, Shulman LN. Affordability of Cancer Drugs in Sub-Saharan Africa: Effects of Pricing on Needless Loss of Life. JAMA Oncol. 2017;3(10):1301–1302. doi:10.1001/jamaoncol.2017.0479
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: